Skip to Content
Merck
  • Magnetic resonance cholangiopancreatography: potential usefulness of dehydrocholic acid (DHCA) administration in the evaluation of anastomotic site.

Magnetic resonance cholangiopancreatography: potential usefulness of dehydrocholic acid (DHCA) administration in the evaluation of anastomotic site.

Hepato-gastroenterology (2008-05-30)
Yuji Sakai, Toshio Tsuyuguchi, Seigo Yukisawa, Shin Tsuchiya, Harutoshi Sugiyama, Kaoru Miyakawa, Yoshihiro Fukuda, Masaaki Ebara, Hiroi Nonaka, Hiroo Ikehira, Takayuki Obata, Osamu Yokosuka, Masaru Miyazaki
ABSTRACT

The aim of this study was to investigate whether exogenous dehydrocholic acid (DHCA) was useful to enhance the delineation of anastomotic site. DHCA is a cholagogue which produces an immediate effect by acting directly on liver cells. Its choleretic effect is strong, appearing 1 to 3 minutes after intravenous injection, reaching the maximum level in 20 to 30 minutes. Our study population comprised 9 patients. Magnetic resonance cholangiopancreatography (MRCP) was acquired before and after the administration of DHCA. Two different MRCP snap-shot techniques were applied: thick-slab two-dimensional (2D) (coronal) single-shot turbo spin echo T2-weighted sequences and multisection thin-slab, 2D (coronal) single shot turbo spin echo T2-weighted sequences with three-dimensional (3D) maximum intensity projection (MIP) post processing. DHCA provided a better visualization of the anastomotic site in 7 patients (77.8%). The two patients without improvement in visualization of anastomotic site included 1 patient with liver cirrhosis secondary to portoenterostomy for congenital biliary dilatation and 1 patient, who was not eligible for the evaluation because of motion artifact caused by the difficulty of breath holding motion artifact. It was suggested that administration of DHCA could enhance the delineation of the anastomotic site on MRCP images.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Dehydrocholic acid, ≥99.0% (T)